Calcium intake did not affect cardiovascular health

Medical experts say there is no excuse to suspend calcium intake or calcium mineral supplements and that everyone should consume between 500 and 1,000 milligrams per day to prevent osteoporosis and, consequently, the risk of fractures. Controversy indicated that calcium intake promoted the formation of atheromatous plaques and increased the risk of heart attack was ruled out after it was shown that there was an error in the research methodology.

It is extremely useful for bone health and is necessary to maintain a diet greater than 500 milligrams per day, the maximum is 1,000 milligrams daily. If less, the body moves the bone calcium for vital functions support, which are known as negative calcium balance

The ideal form of calcium ingested is through the diet. Points out that a glass of milk or yogurt, contains 300 milligrams, 4 sardines, 500 milligrams; cheese, between 200 and 300 milligrams, green vegetables, such as cauliflower and broccoli also contain the mineral. 

Source

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...